Momenta announces jury verdict in Enoxaparin Sodium injection patent litigation
Momenta announced the jury in the District Court for the District of Massachusetts in Boston has issued its verdict finding \the Company's U.S. Patent No. 7,575,886, covering methods for \manufacturing of generic LOVENOX® (Enoxaparin Sodium Injection), was infringed, but invalid and unenforceable. July 21, 2017